European Union



2d paediatric strategy forum on medicine development for mature B cell malignancies in children

A room in a pediatric hospital © EU
Start date : 13/11/2017
End date : 14/11/2017
London, United Kingdom
European Medicines Agency, Other bodies and agencies,
Consumer affairs and public health,

This second multi-stakeholder paediatric strategy forum, jointly organised by ACCELERATE and the European Medicines Agency (EMA), will focus on mature B cell malignancies (lymphoma and leukaemia) in children.

The goal of this meeting is to share information, in a precompetitive setting, which will inform a paediatric drug development strategy and subsequent decisions and facilitate the developments of innovative medicines for the treatment of children with mature B cell malignancies.

Interested parties, including patients and parent-representatives, academia, clinicians and industry, should express their interest. For clinicians and researchers, priority will be given to those who have expertise and experience in clinical trials for mature B cell malignancies in children or intend to design such studies in the future.


More information on the event




Back to top